Two centuries of vaccination: historical and conceptual approach and future perspectives

Front Public Health. 2024 Jan 9:11:1326154. doi: 10.3389/fpubh.2023.1326154. eCollection 2023.

Abstract

Over the past two centuries, vaccines have been critical for the prevention of infectious diseases and are considered milestones in the medical and public health history. The World Health Organization estimates that vaccination currently prevents approximately 3.5-5 million deaths annually, attributed to diseases such as diphtheria, tetanus, pertussis, influenza, and measles. Vaccination has been instrumental in eradicating important pathogens, including the smallpox virus and wild poliovirus types 2 and 3. This narrative review offers a detailed journey through the history and advancements in vaccinology, tailored for healthcare workers. It traces pivotal milestones, beginning with the variolation practices in the early 17th century, the development of the first smallpox vaccine, and the continuous evolution and innovation in vaccine development up to the present day. We also briefly review immunological principles underlying vaccination, as well as the main vaccine types, with a special mention of the recently introduced mRNA vaccine technology. Additionally, we discuss the broad benefits of vaccines, including their role in reducing morbidity and mortality, and in fostering socioeconomic development in communities. Finally, we address the issue of vaccine hesitancy and discuss effective strategies to promote vaccine acceptance. Research, collaboration, and the widespread acceptance and use of vaccines are imperative for the continued success of vaccination programs in controlling and ultimately eradicating infectious diseases.

Keywords: health literacy; history of vaccines; types of vaccines; vaccine development; vaccine hesitancy; vaccines; vaccinology.

Publication types

  • Review

MeSH terms

  • Antigens, Viral
  • Communicable Diseases*
  • Humans
  • Immunization
  • Influenza Vaccines*
  • Vaccination

Substances

  • Antigens, Viral
  • Influenza Vaccines

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by Postdoctoral FONDECYT project 3190524, awarded to DM and Regular FONDECYT Project 1211647, awarded to RV.